Gabriela Hernandez-Vega
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
SOLAR: a noninterventional study of outcomes over the long term of people with cystic fibrosis (CF) aged ≥6 years treated with elexacaftor/tezacaftor/ivacaftor using data from the French CF Registry.
Journal: ERJ open research
Published: January 05, 2026
Real-World Impact of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Italy: A Retrospective Study from a Cystic Fibrosis Center.
Journal: Pulmonary therapy
Published: July 29, 2025
LONGITUDE: An observational study of the long-term effectiveness of elexacaftor/tezacaftor/ivacaftor in people aged ≥12 years with cystic fibrosis using data from the United Kingdom Cystic Fibrosis Registry - 2-year analysis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 10, 2024
Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 24, 2022
Caregiver burden in cystic fibrosis: a systematic literature review.
Journal: Therapeutic advances in respiratory disease
Published: March 24, 2022
Liraglutide Versus Lixisenatide: Long-Term Cost-Effectiveness of GLP-1 Receptor Agonist Therapy for the Treatment of Type 2 Diabetes in Spain.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 22, 2016
Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 15, 2016
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: December 06, 2016
Evaluation of the long-term cost-effectiveness of liraglutide vs lixisenatide for treatment of type 2 diabetes mellitus in the UK setting.
Journal: Diabetes, obesity & metabolism
Published: November 22, 2016
Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes.
Journal: BMJ open diabetes research & care
Published: January 05, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026